Healthcare entity
medical-devices is the sole category represented across all 2 tracked stories. Of the tracked stories, 2 of 2 also mention Citigroup, the most common co-covered peer. The 140-day window averages about 0.1 stories each week. They are less corroborated than the beat average, carrying 2 original sources each against 3.6 for the same window.
Last mentioned: Aug 13, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
medical-devices is the sole category represented across all 2 tracked stories. Of the tracked stories, 2 of 2 also mention Citigroup, the most common co-covered peer. The 140-day window averages about 0.1 stories each week. They are less corroborated than the beat average, carrying 2 original sources each against 3.6 for the same window. Their average consequence score of 5 runs below the beat's 6 for that window. We currently track 2 Healthcare stories that mention Wells Fargo & Company, published between February 21, 2026 and July 10, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 779 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Wells Fargo & Company. Shared-story counts are live from our verified record — not editorial picks.
Analyst downgrades reflect growing fears that GLP-1 weight loss drugs could erode the sleep apnea device market, even as ResMed’s financials stay solid. The contrast between a $225 low target and $321 high target underscores sector uncertainty.
AxoGen (NASDAQ: AXGN) has received a significant rating upgrade to "Strong-Buy" from Wells Fargo, signaling robust institutional confidence in the peripheral nerve repair specialist. This move, coupled with price target hikes from Jefferies and positive outlooks from Citigroup, underscores a bullish sentiment for the company's clinical and commercial trajectory.
Source: Ticker Report · Watch List News
Wells Fargo & Company is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
